B/BE/20/BVW5 - Fiche d'information destinée au public (préparée par le notifiant)

File: 
PDF icon bbe20bvw5_pub_fr.pdf
Trial reference: 
Phase 1b Study to Evaluate the Safety, Tolerability, and Anti-Tumor Activity of Nous-PEV, with pembrolizumab, in Patients with Unresectable Stage III / IV Cutaneous Melanoma and with Stage IV NSCLC
Doc type: 
Information for the public